EA201190071A1 - Производные деоксиактагардина - Google Patents

Производные деоксиактагардина

Info

Publication number
EA201190071A1
EA201190071A1 EA201190071A EA201190071A EA201190071A1 EA 201190071 A1 EA201190071 A1 EA 201190071A1 EA 201190071 A EA201190071 A EA 201190071A EA 201190071 A EA201190071 A EA 201190071A EA 201190071 A1 EA201190071 A1 EA 201190071A1
Authority
EA
Eurasian Patent Office
Prior art keywords
infections
deoksiaktagardina
derivatives
difficile
compounds
Prior art date
Application number
EA201190071A
Other languages
English (en)
Other versions
EA021683B1 (ru
Inventor
Сьёрд Николаас Вадман
Original Assignee
Новакта Биосистемс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новакта Биосистемс Лимитед filed Critical Новакта Биосистемс Лимитед
Publication of EA201190071A1 publication Critical patent/EA201190071A1/ru
Publication of EA021683B1 publication Critical patent/EA021683B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Настоящее изобретение относится в целом к конкретным соединениям-аналогам деоксиактагардина типа А и В. Указанные соединения подходят для применения для лечения микробных инфекций, например, инфекции Clostridiumтакой как С. perfringens, С. difficile, C.tetaniи/или С. botulinumв частности С. difficileв частности инфекции толстой кишки и/или нижних отделов кишечника, и диареи, вызванной микробной инфекцией.
EA201190071A 2009-01-14 2010-01-12 Производные деоксиактагардина в EA021683B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14449009P 2009-01-14 2009-01-14
PCT/GB2010/000042 WO2010082018A1 (en) 2009-01-14 2010-01-12 Deoxyactagardine derivatives

Publications (2)

Publication Number Publication Date
EA201190071A1 true EA201190071A1 (ru) 2012-06-29
EA021683B1 EA021683B1 (ru) 2015-08-31

Family

ID=42110329

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201190071A EA021683B1 (ru) 2009-01-14 2010-01-12 Производные деоксиактагардина в

Country Status (22)

Country Link
US (2) US8283371B2 (ru)
EP (1) EP2387580B1 (ru)
JP (1) JP5719312B2 (ru)
KR (1) KR20110119699A (ru)
CN (1) CN102348718B (ru)
AU (1) AU2010205472B2 (ru)
CA (1) CA2749278A1 (ru)
DK (1) DK2387580T3 (ru)
EA (1) EA021683B1 (ru)
ES (1) ES2520165T3 (ru)
HR (1) HRP20141084T1 (ru)
IL (1) IL213927A0 (ru)
MX (1) MX2011007313A (ru)
NZ (1) NZ594011A (ru)
PL (1) PL2387580T3 (ru)
PT (1) PT2387580E (ru)
RS (1) RS53586B1 (ru)
SG (1) SG172944A1 (ru)
SI (1) SI2387580T1 (ru)
TW (1) TWI453029B (ru)
WO (1) WO2010082018A1 (ru)
ZA (1) ZA201104991B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
ES2520165T3 (es) 2009-01-14 2014-11-11 Novacta Biosystems Limited Derivados de desoxiactagardina
CN102388060B (zh) 2009-02-04 2014-09-10 诺瓦克塔生物系统有限公司 阿肽加定衍生物
WO2011061748A1 (en) * 2009-11-19 2011-05-26 Strides Arcolab Limited Rifaximin premix
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013507D0 (en) * 2010-08-11 2010-09-22 Novacta Biosystems Ltd Compounds
GB201013508D0 (en) * 2010-08-11 2010-09-22 Novacta Biosystems Ltd Compounds
GB201013509D0 (en) * 2010-08-11 2010-09-22 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) * 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
GB201213434D0 (en) 2012-07-27 2012-09-12 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
GB8507528D0 (en) 1985-03-22 1985-05-01 Lepetit Spa Basis monocarboxyamide derivatives
US5304540A (en) 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
IN167138B (ru) * 1988-08-17 1990-09-01 Hoechst India
GB8926639D0 (en) 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
IT1260505B (it) 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
IL107887A (en) * 1992-12-08 2003-07-06 Ambi Inc Stabilized lanthionine containing bacteriocin compositions
US5512269A (en) 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
EP0700998B1 (en) * 1994-09-12 2003-11-26 Aventis Pharma Deutschland GmbH Recombinant mersacidin and a method for production
DE69629691T2 (de) 1995-06-23 2004-02-26 Ambi, Inc. Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US5958873A (en) 1997-06-09 1999-09-28 University Of Cincinnati Oral formulation for treatment of bacteria-induced diseases of the colon
US5985823A (en) * 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
DE19745583A1 (de) 1997-10-15 1999-04-22 Hoechst Marion Roussel De Gmbh Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben
US6569830B1 (en) * 1999-03-05 2003-05-27 Ambi, Inc. Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
DE60105023T2 (de) 2000-06-28 2005-08-18 Smithkline Beecham P.L.C., Brentford Nassvermahlungsverfahren
GB0110432D0 (en) 2001-04-27 2001-06-20 Plant Bioscience Ltd Lantibiotic production
WO2002103010A1 (en) 2001-06-14 2002-12-27 Plant Bioscience Limited Methods and materials for targeted gene disruption in actinomycete bacteria
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
WO2004033706A2 (en) 2002-10-10 2004-04-22 Molichem Medicines, Inc. Nucleic acids encoding duramycin
JP4163737B2 (ja) 2003-07-18 2008-10-08 ヴァイキュロン ファーマシューティカルズ， インコーポレイテッド 抗生物質１０７８９１、そのａ１因子とａ２因子、その薬剤学的に許容される塩、組成物、およびその使用
US7351687B2 (en) 2003-07-18 2008-04-01 Vicuron Pharmaceuticals, Inc. Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
GB0406870D0 (en) 2004-03-26 2004-04-28 Novacta Biosystems Ltd Improvements relating to the production of lantibiotics
JP2009509519A (ja) 2005-09-27 2009-03-12 ノヴァクタ バイオシステムズ リミティッド ランチビオティックメルサシジンの変種およびそれらの使用
GB0600928D0 (en) * 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
US20100168410A1 (en) 2006-10-27 2010-07-01 Pfizer Products Inc. Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture
WO2008151434A1 (en) 2007-06-12 2008-12-18 The University Of British Columbia Small cationic antimicrobial peptides
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
CA2742753A1 (en) 2008-11-24 2010-05-27 Sentinella Pharmaceuticals, Inc. ("Sentinella") Lantibiotic carboxyamide derivatives with enhanced antibacterial activity
GB0900599D0 (en) 2009-01-14 2009-02-18 Novacta Biosystems Ltd Treatment
ES2520165T3 (es) 2009-01-14 2014-11-11 Novacta Biosystems Limited Derivados de desoxiactagardina
CN102388060B (zh) 2009-02-04 2014-09-10 诺瓦克塔生物系统有限公司 阿肽加定衍生物

Also Published As

Publication number Publication date
US20100179207A1 (en) 2010-07-15
EP2387580B1 (en) 2014-08-13
EP2387580A1 (en) 2011-11-23
NZ594011A (en) 2013-12-20
TW201029661A (en) 2010-08-16
CA2749278A1 (en) 2010-07-22
KR20110119699A (ko) 2011-11-02
AU2010205472B2 (en) 2013-03-14
AU2010205472A1 (en) 2011-07-28
MX2011007313A (es) 2011-08-04
IL213927A0 (en) 2011-07-31
ES2520165T3 (es) 2014-11-11
DK2387580T3 (da) 2014-10-13
CN102348718B (zh) 2015-06-03
US20120277145A1 (en) 2012-11-01
WO2010082018A1 (en) 2010-07-22
EA021683B1 (ru) 2015-08-31
PL2387580T3 (pl) 2015-01-30
US8283371B2 (en) 2012-10-09
JP5719312B2 (ja) 2015-05-13
US8741945B2 (en) 2014-06-03
TWI453029B (zh) 2014-09-21
ZA201104991B (en) 2013-10-31
SI2387580T1 (sl) 2014-11-28
JP2012515195A (ja) 2012-07-05
RS53586B1 (sr) 2015-02-27
HRP20141084T1 (hr) 2015-02-13
PT2387580E (pt) 2014-10-30
CN102348718A (zh) 2012-02-08
SG172944A1 (en) 2011-08-29

Similar Documents

Publication Publication Date Title
EA201190071A1 (ru) Производные деоксиактагардина
WO2010063996A3 (en) Antibacterial compounds
GEP20135964B (en) Inhibitors of beta-secretase
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201270423A1 (ru) Ингибиторы протеазы hcv
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
UA111626C2 (uk) Похідні дигідрохінолін-2-ону
EA201590890A1 (ru) Производные 5-фтор-n-(пиридин-2-ил)пиридин-2-амина, содержащие сульфоксиминовую группу
MY153766A (en) Derivatised proline containing peptide organic compounds as protease inhibitors
BR112014015905A2 (pt) composição
BR112012017277A2 (pt) Compostos e métodos
EA201190095A1 (ru) Производные актагардина
EA201390639A1 (ru) Производные 2-пиперазин-1-ил-4н-1,3-бензотиазин-4-она и их применение для лечения инфекций у млекопитающих
MX2011011272A (es) Procesos e intermediarios.
MX2011006803A (es) Agentes antibacterianos novedosos para el tratamiento de infecciones gram positivas.
JO3611B1 (ar) سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
EA201490435A1 (ru) Антибактериальные 3,4-дигидро-1н-[1,8]нафтиридиноны, замещенные пиперидинилом
PH12015500315A1 (en) Substituted pyrozales as n-type calcium channel blockers
MX2012007341A (es) Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
EA201590339A1 (ru) Новые антибактериальные соединения
EA201490436A1 (ru) Антибактериальные 3,4-дигидро-1н-[1,8]нафтиридиноны, замещенные гомопиперидинилом
EA201290446A1 (ru) Полимерные материалы
CY1116238T1 (el) Ενωσεις me αντιβακτηριακη δραστικοτητα εναντι clostridium
WO2011029536A3 (de) Verwendung von cyclischen ketoenolen gegen pflanzenpathogene bakterien
EA201590331A1 (ru) Новые антибактериальные соединения

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU